SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 219 filers reported holding SEATTLE GENETICS INC in Q2 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $46,000 | +15.0% | 600 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $40,000 | +29.0% | 600 | 0.0% | 0.01% | +25.0% |
Q1 2018 | $31,000 | -3.1% | 600 | 0.0% | 0.01% | +14.3% |
Q4 2017 | $32,000 | -3.0% | 600 | 0.0% | 0.01% | -12.5% |
Q3 2017 | $33,000 | +6.5% | 600 | 0.0% | 0.01% | -11.1% |
Q2 2017 | $31,000 | -18.4% | 600 | 0.0% | 0.01% | -25.0% |
Q1 2017 | $38,000 | +18.8% | 600 | 0.0% | 0.01% | -7.7% |
Q4 2016 | $32,000 | 0.0% | 600 | 0.0% | 0.01% | -7.1% |
Q3 2016 | $32,000 | +33.3% | 600 | 0.0% | 0.01% | +40.0% |
Q2 2016 | $24,000 | +14.3% | 600 | 0.0% | 0.01% | +11.1% |
Q1 2016 | $21,000 | -22.2% | 600 | 0.0% | 0.01% | -35.7% |
Q4 2015 | $27,000 | +42.1% | 600 | +20.0% | 0.01% | +27.3% |
Q3 2015 | $19,000 | -20.8% | 500 | 0.0% | 0.01% | -15.4% |
Q2 2015 | $24,000 | -31.4% | 500 | -50.0% | 0.01% | +30.0% |
Q1 2015 | $35,000 | +118.8% | 1,000 | +100.0% | 0.01% | +11.1% |
Q4 2014 | $16,000 | -15.8% | 500 | 0.0% | 0.01% | -25.0% |
Q3 2014 | $19,000 | – | 500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |